BioPharm Systems, Inc. Opens New Regional Office
San Mateo
BioPharm Systems, Inc announced the opening of a new regional office to serve the Europe, Middle East and Africa (EMEA) region. BioPharm Systems, founded in 1995, is a provider of information technology and data management services to the clinical trials industry.
BioPharm is a long-established partner of the Oracle Corporation and provides a wide range of Oracle consulting Services and Products to address needs in clinical data management, electronic data capture, safety and pharmacovigilance reporting, dictionary management, clinical trial management, clinical data analytics and warehousing, systems validation, training and hosting.
Based in North America, BioPharm is now expanding to bring the same services to Clients in the EMEA region, by establishing a new Practice that will be based in the United Kingdom. The practice will be led by Adrian Hampshire, Managing Director EMEA for BioPharm Systems. Adrian Hampshire has served many years in pharmaceutical, biotechnology and CRO organisations in a wide variety of roles.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
